Harrow, Inc. (HROW)
39.10
-1.17
(-2.91%)
USD |
NASDAQ |
May 07, 15:27
Harrow SG&A Expense (TTM) : 152.91M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.56B |
| Esperion Therapeutics, Inc. | 165.79M |
| Hims & Hers Health, Inc. | 1.192B |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Theravance Biopharma, Inc. | 78.40M |